Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Le Coz

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Psychopharmacology|January 1, 1992
Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotilineH Allain, A Lieury, F Brunet-Bourgin, et al.
Journal of Clinical Pharmacology|April 29, 1998
Absolute bioavailability and electroencephalographic effects of conventional and extended-release formulations of venlafaxine in healthy subjectsA Patat, S Troy, J Burke, et al.
Journal of Cardiovascular Pharmacology|July 1, 1991
Oral pharmacokinetics of bisoprolol in resting and exercising healthy volunteersF Le Coz, P Sauleman, J M Poirier, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 18, 1998
Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteersS Chaufour, F Le Coz, T Denolle, et al.
Journal of Clinical Pharmacy and Therapeutics|September 12, 2009
Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosisE Jacquemin, B Hermeziu, Y Kibleur, et al.
Journal of Clinical Pharmacology|March 1, 1996
Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteersA Patat, F le Coz, C Dubruc, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1991
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover studyH Allain, F Le Coz, F Goulley, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Psychopharmacology|January 1, 1992
Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotilineH Allain, A Lieury, F Brunet-Bourgin, et al.
Journal of Clinical Pharmacology|April 29, 1998
Absolute bioavailability and electroencephalographic effects of conventional and extended-release formulations of venlafaxine in healthy subjectsA Patat, S Troy, J Burke, et al.
Journal of Cardiovascular Pharmacology|July 1, 1991
Oral pharmacokinetics of bisoprolol in resting and exercising healthy volunteersF Le Coz, P Sauleman, J M Poirier, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 18, 1998
Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteersS Chaufour, F Le Coz, T Denolle, et al.
Journal of Clinical Pharmacy and Therapeutics|September 12, 2009
Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosisE Jacquemin, B Hermeziu, Y Kibleur, et al.
Journal of Clinical Pharmacology|March 1, 1996
Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteersA Patat, F le Coz, C Dubruc, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1991
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover studyH Allain, F Le Coz, F Goulley, et al.
Pageof 2